 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Evolent Health (NYSE:EVH - Free Report) had its target price cut by Canaccord Genuity Group from $45.00 to $44.00 in a research report report published on Thursday, Benzinga reports. They currently...

Canaccord Genuity Group Lowers Evolent Health (NYSE:EVH) Price Target to $44.00

Evolent Health, Inc. (NYSE:EVH  Get Free Report) has received an average rating of Moderate Buy from the twelve analysts that are presently covering the stock, Marketbeat.com...

Evolent Health, Inc. (NYSE:EVH) Given Average Recommendation of "Moderate Buy" by Analysts

Latest Ratings for EVH
 DateFirmActionFromTo Nov 2021JP MorganUpgradesNeutralOverweight Aug 2021Canaccord GenuityMaintainsBuy Mar 2021Canaccord GenuityMaintainsBuy
 View More Analyst Ratings for...

Navigating 4 Analyst Ratings For Evolent Health

Northern Trust Corp boosted its stake in shares of Evolent Health, Inc. (NYSE:EVH  Free Report) by 2.5% in the 3rd quarter, according to the company in its most recent disclosure with the...

Northern Trust Corp Buys 29,692 Shares of Evolent Health, Inc. (NYSE:EVH)

Kennedy Capital Management LLC boosted its stake in Evolent Health, Inc. (NYSE:EVH  Free Report) by 6.2% in the third quarter, according to the company in its most recent 13F filing with the...

Kennedy Capital Management LLC Buys 20,959 Shares of Evolent Health, Inc. (NYSE:EVH)

This is a signal that EVH's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...

Evolent Health (EVH, $34.04) RSI Indicator left the overbought zone on March 05, 2024

Truist Financial analyst Jailendra Singh assigned a Hold rating to the stock today. The company's shares closed yesterday at $34.72. According to T...

Evolent Health (EVH) Gets a Hold from Truist Financial

Evolent Health (EVH, $34.72) RSI Indicator left the overbought zone on March 04, 2024

Oppenheimer began coverage on shares of Evolent Health (NYSE:EVH  Free Report) in a report issued on Friday, Marketbeat reports. The brokerage issued an outperform rating and a $45.00 price...

Evolent Health (NYSE:EVH) Coverage Initiated at Oppenheimer

Evolent Health, Inc. (NYSE:EVH  Get Free Report) has earned an average recommendation of Moderate Buy from the ten analysts that are covering the company, MarketBeat Ratings...

Evolent Health, Inc. (NYSE:EVH) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Evolent Health, Inc. engages in the provision of healthcare delivery and payment services. It deals with population health management, health plan and third party administration, network performance and pharmacy benefit management, risk adjustment, analytics and performance improvement, and technology and electronic medical record integration. The firm operates through Services and True Health segments. The Services segment includes clinical and administrative solutions such as total cost of care management and specialty care management and comprehensive health plan administrative services. The True Health segment offers a physician-led health plan for employer-sponsored health coverage. The company was founded by Frank J. Williams, Seth B. Blackley, and Thomas Peterson III in August 2011 and is headquartered in Arlington, VA.

Volume (M)	608,791.00
52-Wk High	$36.70
52-Wk Low	$23.33

EVH Evolent Health Inc - Ordinary Shares - Class A

About

Feed

News

Sentiment

Earnings

Fundamentals